Streetbeat News

Products Services

INTC

Intel Corp's CEO has confirmed that all programs in chip manufacturing are on schedule, as per the latest conference call.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 9:08 pm

F

Ford's CFO has stated that the slowdown in electric vehicle (EV) demand is due to the high cost of these vehicles, not a lack of demand. This statement suggests that the affordability of EVs is a significant factor in their market penetration.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 8:46 pm

KRMD

KORU Medical Systems, Inc. (NASDAQ:KRMD) has announced a collaboration with a biopharmaceutical company to validate its FREEDOM™ Infusion System for use with the biopharma company's novel biologic. The drug developer is expected to begin Phase III studies by the end of 2023 for treatment of a rare genetic disease. This agreement adds to KORU Medical's previously announced collaborations for Phase II and Phase III studies of treatments for various diseases.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 8:42 pm

F

Ford's CFO has reaffirmed the company's target of producing 150,000 units of the Lightning model this year, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 8:38 pm

F

Ford's CFO has confirmed that there will be no changes to the production plans for the F-150 Lightning, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 8:36 pm

F

Ford's CFO has stated that the company is not providing a date for when it will be able to produce 2 million electric vehicles (EVs) annually. This is a change from their previous target of the end of 2026.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 8:35 pm

SCTL

Societal CDMO Inc. (NASDAQ:SCTL) has secured a DEA Schedule 1 Controlled Substances manufacturer’s license, allowing it to enter the biopharma industry’s psychedelic drugs subsection. This expands Societal’s drug development capabilities, building on its 25 years of experience manufacturing Schedule 2 compounds. The company will now offer research and commercial customers high-quality cGMP clinical psychedelic supplies.

Portfolio Pulse from Lara Goldstein

July 27, 2023 | 8:24 pm

FUBO

HIMS

TMUS

Actor Ryan Reynolds is bringing back the popular 1980s television character ALF through his Maximum Effort Channel in partnership with fuboTV Inc (NYSE:FUBO). The character will be part of sponsored content for companies like Fubo, Hims & Hers (NYSE:HIMS), MNTN, Ring, and Mint Mobile, which Reynolds agreed to sell to T-Mobile US (NASDAQ:TMUS). The new sponsored content could potentially increase interest in the Maximum Effort Channel and highlight its value.

Portfolio Pulse from Chris Katje

July 27, 2023 | 7:54 pm

AAPL

Lionel Messi's move to Major League Soccer (MLS) has reportedly boosted viewership on Apple's MLS streaming service, according to The Verge. This could potentially increase Apple's revenues from its streaming service.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 7:54 pm

MRSN

Mersana Therapeutics announced that the UPLIFT clinical trial of upifitamab rilsodotin did not meet its primary endpoint, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 7:28 pm